Home > Income Statement > NATCO PHARMA

NATCO PHARMA
Appropriations

    Back to Income Statement
NATCO PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATCO PHARMA
Please provide your vote to see the results

NATCO PHARMA Last 5 Year Appropriations History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Appropriations ₹4,681 Cr₹3,382 Cr₹2,738 Cr₹2,680 Cr₹2,398 Cr

What is the latest Appropriations of NATCO PHARMA ?

The latest Appropriations ratio of NATCO PHARMA is ₹4,681 Cr based on Mar2024 Consolidated results.
Year Appropriations
Mar2024₹4,681 Cr
Mar2023₹3,382 Cr
Mar2022₹2,738 Cr
Mar2021₹2,680 Cr
Mar2020₹2,398 Cr

How is Appropriations of NATCO PHARMA Trending?

Years Appropriations % Change
Mar2024 ₹4,681 Cr
38.40
Mar2023 ₹3,382 Cr
23.51
Mar2022 ₹2,738 Cr
2.17
Mar2021 ₹2,680 Cr
11.76
Mar2020 ₹2,398 Cr -

Compare Appropriations of peers of NATCO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATCO PHARMA ₹14,710.4 Cr 1% 6.5% -15.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,971.0 Cr -4.6% 0.7% 10.8% Stock Analytics
DIVIS LABORATORIES ₹161,153.0 Cr -1.2% 12.6% 51.2% Stock Analytics
CIPLA ₹122,717.0 Cr 0.7% 6% 9.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,392.0 Cr -1.8% -0.4% 25.1% Stock Analytics
DR REDDYS LABORATORIES ₹100,702.0 Cr 4% 8.9% -1.3% Stock Analytics


NATCO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATCO PHARMA

1%

6.5%

-15.3%

SENSEX

0.6%

11%

10.4%


You may also like the below Video Courses